Association between adenosine receptor gene polymorphism and response to caffeine citrate treatment in apnea of prematurity : an Egyptian single-center study

Joint Authors

Zaydan, Nahlah
Mukhtar, Wisam A.
Allam, Rim M.
Hamid, Muna S.
Fawzi, Amal

Source

Egyptian Pediatric Association Gazette

Issue

Vol. 66, Issue 4 (31 Dec. 2018), pp.115-120, 6 p.

Publisher

Egyptian Pediatric Association

Publication Date

2018-12-31

Country of Publication

Egypt

No. of Pages

6

Main Subjects

Pharmacy, Health & Medical Sciences

Abstract EN

Background: Caffeine citrate is the methyl-xanthine of choice used in controlling apnea of prematurity (AOP).

Caffeine central effect is mediated via non-selective (AO and selective (A;*) adenosine receptors antagonism.

Variability in caffeine response had been frequently noticed in AOP, suggesting underlying genetic predisposition.

Aim of the study: We evaluated the role of adenosine receptor Ax [ADORAJ and adenosine receptor A^ [ADORA2a] gene polymorphisms in the variability of caffeine response among Egyptian preemies with AOP.

Patient and methods: In this case-control study, 43 preterm neonates with AOP were eligible as cases and 43 preterm babies free from apnea were taken as controls.

Preterm neonates with AOP were further divided ac- cording to response to caffeine treatment into caffeine responder (n = 18) and caffeine non-responders (n = 25).

ADORAj [716 T > G] and ADORA2a [1976C > T] gene polymorphisms were genotyped by mean of PCR-based RFLP-assay.

Results: There were significant increase in frequency distribution of ADORA2a [1976C > T] CT (62.7% vs 23.3%), TT (14% vs 4.7%) genotypes and T allele (34.3% vs 16.3%) in cases compared to controls with sig- nificant increased risk of AOP development with OR (95%CI); P-value of 8.37(3.03-23.1), P = 0.000; 9.3(1.61-53.61), P = 0.005 and 4.27(2.09-8.70), P = 0.000 respectively.

Further, caffeine non-responders were associated with significant increase frequency of ADORA2a CT (80% vs 38.9%) and TT (16% vs 11.1%) geno-types and T allele (56% vs 30.6%) with OR (95%CI) and P-value of 21.38 (2.31-197.8), P = 0.001; 18 (1.24-260.9); P = 0.005 and 2.89(1.17-7.13), P = 0.019 respectively, when compared to caffeine responders.

Patients with AOP who had ADORA2a CT and TT genotypes were associated with significant increase in duration of hospital stay and poor outcome.

Genotype distribution frequency of studied polymorphisms did not deviate from Hardy Weinberg (HW) equilibrium among controls.

Conclusion: ADORA2a [1976C > T] polymorphism has a significant role in AOP development and variation in caffeine response among preterm babies.

American Psychological Association (APA)

Mukhtar, Wisam A.& Fawzi, Amal& Allam, Rim M.& Zaydan, Nahlah& Hamid, Muna S.. 2018. Association between adenosine receptor gene polymorphism and response to caffeine citrate treatment in apnea of prematurity : an Egyptian single-center study. Egyptian Pediatric Association Gazette،Vol. 66, no. 4, pp.115-120.
https://search.emarefa.net/detail/BIM-855556

Modern Language Association (MLA)

Mukhtar, Wisam A.…[et al.]. Association between adenosine receptor gene polymorphism and response to caffeine citrate treatment in apnea of prematurity : an Egyptian single-center study. Egyptian Pediatric Association Gazette Vol. 66, no. 4 (Dec. 2018), pp.115-120.
https://search.emarefa.net/detail/BIM-855556

American Medical Association (AMA)

Mukhtar, Wisam A.& Fawzi, Amal& Allam, Rim M.& Zaydan, Nahlah& Hamid, Muna S.. Association between adenosine receptor gene polymorphism and response to caffeine citrate treatment in apnea of prematurity : an Egyptian single-center study. Egyptian Pediatric Association Gazette. 2018. Vol. 66, no. 4, pp.115-120.
https://search.emarefa.net/detail/BIM-855556

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references : p. 119-120

Record ID

BIM-855556